FDA
-
-
-
-
-
-
-
Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound Debridement
-
-
-
-
-
-
-
MediWound to Present at Upcoming Investor Conferences
-
-
-
-
-
-
-
MediWound to Report Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
MediWound’s NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress
-
-
-
-
-
-
-
MediWound (MDWD) Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers
-
-
-
-
-
-
-
MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care
-
-
-
-
-
-
-
MediWound to Report Third Quarter 2024 Financial Results
-
330,175 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

